Send the following on WhatsApp
Continue to ChatCyclo Therapeutics Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease https://cyclodextrinnews.com/2021/12/07/cyclo-therapeutics-receives-ind-clearance-from-the-u-s-fda-to-advance-its-phase-2-study-of-trappsol-cyclo-for-the-treatment-of-alzheimers-disease/